High-risk Influenza Vaccine Alert
Study Details
Study Description
Brief Summary
The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
The CDC recommends a flu vaccination to everyone aged 6+ months, with rare exception; almost anyone can benefit from the vaccine, which can reduce illnesses, missed work, hospitalizations, and death. One barrier to vaccination is a lack of "cues to action," and, in particular, the lack of direct recommendation from medical personnel; this barrier is arguably the most effectively overcome by a simple nudge of clinicians, compared with barriers such as negative attitudes toward vaccination, low perceived utility of vaccination, and less experience with having received the vaccine.
Eligible patients will be randomized to an active control group (clinician will be shown a standard flu alert) or one of two experimental groups (clinician will be shown an alert indicating patient's high risk, with or without describing the patient's factors contributing to that risk).
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Standard Alert Standard flu alert |
Behavioral: Alert
Non-interruptive best practice alert in the electronic health record
|
Experimental: High-risk Alert Flu alert that indicates patient is at high risk for flu and its complications |
Behavioral: Alert
Non-interruptive best practice alert in the electronic health record
Behavioral: Salient alert features
Larger alert header and body font size, use of different font colors and boldface
Behavioral: High-risk Text
Alert header indicates patient is at high risk for flu and its complications; alert body indicates the percentage of risk (e.g., in the top 3% of risk)
|
Experimental: High-risk Alert with Risk Factors Flu alert that indicates patient is at high risk for flu and its complications and presents the factors contributing to this high risk |
Behavioral: Alert
Non-interruptive best practice alert in the electronic health record
Behavioral: Salient alert features
Larger alert header and body font size, use of different font colors and boldface
Behavioral: High-risk Text
Alert header indicates patient is at high risk for flu and its complications; alert body indicates the percentage of risk (e.g., in the top 3% of risk)
Behavioral: Risk factors
Alert body indicates the top 3 factors contributing to the high risk
|
Outcome Measures
Primary Outcome Measures
- Flu vaccination [At the 1 day visit]
Patient receives a flu vaccine (yes/no)
Other Outcome Measures
- High confidence flu diagnosis [Up to 8 months]
Patient received a flu diagnosis via a positive PCR/antigen/molecular test (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023).
- "Likely flu" diagnosis [Up to 8 months]
Received a "high confidence flu" diagnosis (with positive polymerase chain reaction [PCR]/antigen/molecular test) and/or "likely flu" diagnosis (as assessed via International Classification of Disease [ICD] codes or Tamiflu administration or positive PCR/antigen/molecular test) (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023). Note that "likely flu" is a superset of the "high confidence flu" diagnoses.
- Flu complications [Up to 8 months]
Diagnosed with flu-related complications (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023).
- ER visits [Up to 11 months]
Number of ER visits from the patient's message appointment date through July 31, 2023
- Hospitalizations [Up to 11 months]
Number of hospitalizations from the patient's message appointment date through July 31, 2023
- COVID-19 vaccination rates [Up to 8 months]
Received at least one COVID-19 vaccination (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023).
- Flu vaccination during the 2022-2023 season [Up to 8 months]
Patient receives a flu vaccine (yes/no) during the 2022-23 flu season (from the patient's appointment date through April 30, 2023).
Eligibility Criteria
Criteria
Patient Inclusion Criteria:
-
Age 18+
-
On a list of active Geisinger patients (patients on this list attended at least one primary care appointment at Geisinger between 10/1/2008 and 4/13/2022, and either had a Geisinger primary care provider assigned as of April 2022, or were in the electronic health record since at least September 2021 and had at least one encounter in 2020-2022)
-
Has been determined to be high risk via a machine learning algorithm among eligible patients (about 20% of patients are expected to be at significantly elevated risk)
-
Attend an appointment where the flu alert fires (Geisinger sets when flu alerts start and ends--between ~9/1/2022 and ~4/30/2023, as well as the trigger conditions for the alert, which includes valid departments and visits and excludes contraindications like Guillain-Barre syndrome)
Clinician Inclusion Criteria:
- Any Geisinger clinician who sees patient-participants in our study for an appointment where their flu shot alert fires
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Geisinger Clinic
Investigators
- Principal Investigator: Christopher F Chabris, PhD, Geisinger Clinic
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2022-0502